Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
- Language
-
Englisch
- Identifier
-
1247674266
Contributor
Tolksdorf, Beatrice
Zarif, Sina
Eberle, Jürgen
Hazini, Ahmet
Dieringer, Babette
Jönsson, Franziska
Kreppel, Florian
Kurreck, Jens
Fechner, Henry
Zarif, Sina
Eberle, Jürgen
Hazini, Ahmet
Dieringer, Babette
Jönsson, Franziska
Kreppel, Florian
Kurreck, Jens
Fechner, Henry
- DOI
-
10.14279/depositonce-12755
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:57 PM CET
Associated
- Tolksdorf, Beatrice
- Zarif, Sina
- Eberle, Jürgen
- Hazini, Ahmet
- Dieringer, Babette
- Jönsson, Franziska
- Kreppel, Florian
- Kurreck, Jens
- Fechner, Henry
Other Objects (12)
MiR‐375‐mediated suppression of engineered coxsackievirus B3 in pancreatic cells
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Studien zur endogenen Expression von RNA G-Quadruplexen und deren Interaktion mit zellulären Proteinen
Anti-adenoviral artificial microRNAs Expressed from AAV9 vectors inhibit human adenovirus infection in immunosuppressed Syrian hamsters
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
RNA-Interferenz-basierte Therapien bei Adenovirusinfektionen im immunsupprimierten Wirt
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
MiR‐375‐mediated suppression of engineered coxsackievirus B3 in pancreatic cells
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Studien zur endogenen Expression von RNA G-Quadruplexen und deren Interaktion mit zellulären Proteinen
Anti-adenoviral artificial microRNAs Expressed from AAV9 vectors inhibit human adenovirus infection in immunosuppressed Syrian hamsters
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
RNA-Interferenz-basierte Therapien bei Adenovirusinfektionen im immunsupprimierten Wirt
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
MiR‐375‐mediated suppression of engineered coxsackievirus B3 in pancreatic cells
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
Development of recombinant oncolytic Coxsackievirus B3 for treatment of colorectal carcinoma
Studien zur endogenen Expression von RNA G-Quadruplexen und deren Interaktion mit zellulären Proteinen
Anti-adenoviral artificial microRNAs Expressed from AAV9 vectors inhibit human adenovirus infection in immunosuppressed Syrian hamsters
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
RNA-Interferenz-basierte Therapien bei Adenovirusinfektionen im immunsupprimierten Wirt